Menu Search
Equities

Tong Ren Tang Technologies Co Ltd

TGRNF:PKC

Tong Ren Tang Technologies Co Ltd

Actions
  • Price (USD)0.6883
  • Today's Change0.00 / 0.00%
  • Shares traded50.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 29 2024 12:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tong Ren Tang Technologies Co Ltd is a China-based company mainly engaged in the manufacture and sale of traditional Chinese medicine products. The Company's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The Company is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The Company mainly distributes its products in the domestic market and overseas markets.

  • Revenue in HKD (TTM)7.41bn
  • Net income in HKD701.46m
  • Incorporated2000
  • Employees4.01k
  • Location
    Tong Ren Tang Technologies Co LtdNo. 20 South Sanhuan Middle RoadFengtai DistrictBEIJING 100079ChinaCHN
  • Phone+86 1 087632888
  • Websitehttps://www.tongrentangkj.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.